Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/121235| Title: | Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?' |
| Author: | Llovet i Bayer, Josep Maria Johnson, Philip J. |
| Keywords: | Assaigs clínics de medicaments Càncer de fetge Drug testing Liver cancer |
| Issue Date: | 20-Mar-2014 |
| Publisher: | American Society of Clinical Oncology |
| Note: | Reproducció del document publicat a: https://doi.org/10.1200/JCO.2013.54.3033 |
| It is part of: | Journal of Clinical Oncology, 2014, vol. 32, num. 9, p. 968-969 |
| URI: | http://hdl.handle.net/2445/121235 |
| Related resource: | https://doi.org/10.1200/JCO.2013.54.3033 |
| ISSN: | 0732-183X |
| Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 645640.pdf | 58.01 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.